THE USE OF ANALGESICS AND BARRIERS TO CANCER PAIN MANAGEMENT IN K2 HOSPITAL
Main Article Content
Abstract
Objectives: To investigate analgesic prescribing, pain medication adherence and patient barriers to cancer pain management. Methods: Across-sectional studywas conducted, patients wereface-to-face interviewedor via telephonewith a questionnaire. Results: 46 patientsparticipated the study (mean age: 57.5). Lungcancer wasthe most common cancer. Most patients weresuffering moderate pain (63%) and severe pain (21.7%). The most common analgesic regimen was tramadol+paracetamol. The rate of patients not adherenceis 65.2%; 19.6% of patients did not know the instructions of using analgesics. From 47.5% to 100% of patients agree with issues such as pain medication should only be used when pain, pain is a natural course of the disease that must be endured, fear of side effects and fear of pain medication will gradually lose its effect. Conclusion: Nearly two-third of patients in the study did not adhere with the use of analgesics; and major patient barriers to cancer pain management include: failure to understand dosing instructions, the notion that pain medications should only be taken when in pain, endure the pain without treatment, fear of side effects, and fear of tolerance. Interventions are needed to improve medication adherence and reduce barriers to cancer pain management.
Article Details
Keywords
Cancer pain management, barriers, adherence, K hospital
References
2. Bandieri E., Romero M., Ripamonti C. I., Artioli F., Sichetti D., Fanizza C., Santini D., Cavanna L., Melotti B., Conte P. F., Roila F., Cascinu S., Bruera E., Tognoni G., Luppi M.
(2016), "Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain", J Clin Oncol, 34(5), pp. 436-42.
3. National Comprehensive Cancer Network (2020), Adult cancer pain, pp.
4. Oldenmenger WH, Sillevis Smitt PA, van Dooren S, Stoter G, CC van der Rijt (2009), "A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal", Eur J Cancer, 45(8), pp. 1370-1380.
5. Van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, DJ Janssen (2016), "Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis", J Pain Symptom Manage, 51(6), pp. 1070-1090.
6. World Health Organization (2018), WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents, pp.
7. Xu X., Luckett T., Wang A. Y., Lovell M., Phillips J. L. (2018), "Cancer pain management needs and perspectives of patients from Chinese backgrounds: a systematic review of the Chinese and English literature", Palliat Support Care, 16(6), pp. 785-799.